Viela Bio, Inc. logo
Viela Bio, Inc. VIE

Viela Bio, Inc. Retained Earnings 2011-2026 | VIE

Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.
Possible uses include
  • reinvestment in development (R&D, equipment, marketing)
  • debt repayment
  • acquisition of other companies
  • creation of reserves for the future

A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.

The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.

Annual Retained Earnings Viela Bio, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-427 M -277 M -190 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-190 M -427 M -298 M

Retained Earnings of other stocks in the Biotechnology industry

Issuer Retained Earnings Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
-158 M - 2.43 % $ 254 M germanyGermany
argenx SE argenx SE
ARGX
-861 M $ 834.06 0.94 % $ 25 B niderlandNiderland
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
-611 M $ 234.24 -0.3 % $ 5 B danmarkDanmark
Harmony Biosciences Holdings Harmony Biosciences Holdings
HRMY
161 M $ 27.99 4.17 % $ 1.59 B usaUSA
ARCA biopharma ARCA biopharma
ABIO
-83.7 M - 1052.0 % $ 415 M usaUSA
Acasti Pharma Acasti Pharma
ACST
-221 M - 4.01 % $ 150 M canadaCanada
Aptorum Group Limited Aptorum Group Limited
APM
-72.4 M $ 0.81 1.31 % $ 4.42 M chinaChina
Adverum Biotechnologies Adverum Biotechnologies
ADVM
-1.07 B - - $ 86.2 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
-131 M - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
-1.13 B - - $ 1.01 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
-223 M - 1.93 % $ 17.4 M usaUSA
I-Mab I-Mab
IMAB
-8.33 B - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.24 B - - $ 40.3 B usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
-826 M - - $ 3.67 B usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
-182 M $ 3.33 0.79 % $ 8.01 B australiaAustralia
Biophytis SA Biophytis SA
BPTS
-17.1 M - -13.47 % $ 169 M franceFrance
Albireo Pharma Albireo Pharma
ALBO
-301 M - -0.23 % $ 916 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
-246 M - 3.16 % $ 1.9 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
-108 M - -1.52 % $ 24.7 M usaUSA
AlloVir AlloVir
ALVR
-715 M - 4.14 % $ 49.1 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-122 M - -18.52 % $ 27.3 M britainBritain
Akouos Akouos
AKUS
-168 M - 0.23 % $ 488 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-243 M - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
-366 M - - $ 10.1 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
-1.19 B - -24.86 % $ 820 K usaUSA
Acer Therapeutics Acer Therapeutics
ACER
-141 M - 2.71 % $ 14 M usaUSA
Aravive Aravive
ARAV
-616 M - -13.39 % $ 1.45 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
69.4 M - - - russiaRussia
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
-308 M - - $ 26.5 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
-103 M - -52.27 % $ 4.45 M usaUSA
Atea Pharmaceuticals Atea Pharmaceuticals
AVIR
-364 M $ 4.66 1.42 % $ 393 M usaUSA
Axsome Therapeutics Axsome Therapeutics
AXSM
-1.31 B $ 167.61 -4.09 % $ 8.34 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-149 M - - $ 7.46 M israelIsrael
Atreca Atreca
BCEL
-457 M - -11.76 % $ 5.79 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
-224 M - - $ 2.17 B usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
-256 M - -4.8 % $ 255 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-335 M - 5.93 % $ 314 M canadaCanada
BeiGene, Ltd. BeiGene, Ltd.
BGNE
-8.61 B - 0.49 % $ 251 B cayman-islandsCayman-islands
Biogen Biogen
BIIB
20.6 B $ 194.87 -0.75 % $ 28.5 B usaUSA
BioVie BioVie
BIVI
-352 M $ 1.25 0.4 % $ 1.85 M usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
-575 M - -9.72 % $ 5.89 M usaUSA
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
-195 M $ 63.02 0.15 % $ 12 B usaUSA
Baudax Bio Baudax Bio
BXRX
-191 M - 0.59 % $ 63 K usaUSA
Aptose Biosciences Aptose Biosciences
APTO
-541 M - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
-353 M - -39.0 % $ 4.57 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
-196 M - 17.91 % $ 11.1 M usaUSA
BioNTech SE BioNTech SE
BNTX
-410 M $ 110.88 0.86 % $ 27.2 B germanyGermany
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
-607 M $ 14.72 2.08 % $ 4.55 B usaUSA
Calithera Biosciences Calithera Biosciences
CALA
-491 M - -10.95 % $ 876 K usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
-2.12 B - -6.81 % $ 3.04 B usaUSA